Heather Walker

516 total citations
9 papers, 312 citations indexed

About

Heather Walker is a scholar working on Molecular Biology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Heather Walker has authored 9 papers receiving a total of 312 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Genetics and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Heather Walker's work include Chronic Lymphocytic Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cell Adhesion Molecules Research (2 papers). Heather Walker is often cited by papers focused on Chronic Lymphocytic Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Cell Adhesion Molecules Research (2 papers). Heather Walker collaborates with scholars based in United States, Canada and Switzerland. Heather Walker's co-authors include John M. Whitelock, Mary C.M. Weiser‐Evans, Pamela J. Garl, Paul Kwon, Kenneth W. Bair, Peter Atadja, Lidia Sambucetti, Stacy Remiszewski, Raphael A. Nemenoff and Manfred Jung and has published in prestigious journals such as Blood, Circulation Research and Cancer Research.

In The Last Decade

Heather Walker

8 papers receiving 301 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heather Walker United States 5 223 53 49 48 46 9 312
Yoh Terada Japan 8 326 1.5× 64 1.2× 49 1.0× 75 1.6× 136 3.0× 15 483
Jienan Kong China 9 293 1.3× 113 2.1× 28 0.6× 20 0.4× 53 1.2× 13 408
Sue Jin United States 6 77 0.3× 107 2.0× 60 1.2× 37 0.8× 43 0.9× 6 300
Celia Sharp United States 6 131 0.6× 94 1.8× 124 2.5× 94 2.0× 30 0.7× 7 330
Andreas Timmermann Germany 7 74 0.3× 124 2.3× 23 0.5× 66 1.4× 21 0.5× 15 348
Irina Häuselmann Switzerland 3 291 1.3× 92 1.7× 25 0.5× 62 1.3× 54 1.2× 3 378
Simon McAdam United Kingdom 10 242 1.1× 50 0.9× 59 1.2× 40 0.8× 58 1.3× 12 431
Kristen Bisanz United States 6 287 1.3× 124 2.3× 20 0.4× 9 0.2× 47 1.0× 7 389
Mina Aikawa United States 8 430 1.9× 79 1.5× 10 0.2× 74 1.5× 33 0.7× 8 503
Deanna N. Parke United States 11 192 0.9× 165 3.1× 26 0.5× 130 2.7× 39 0.8× 18 432

Countries citing papers authored by Heather Walker

Since Specialization
Citations

This map shows the geographic impact of Heather Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Walker more than expected).

Fields of papers citing papers by Heather Walker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Walker. The network helps show where Heather Walker may publish in the future.

Co-authorship network of co-authors of Heather Walker

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Walker. A scholar is included among the top collaborators of Heather Walker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Walker. Heather Walker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ahn, Inhye E., David C. Fisher, Austin I. Kim, et al.. (2024). A Phase 2 Study of Zanubrutinib and Venetoclax (ZV) in Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL). Blood. 144(Supplement 1). 1874–1874.
2.
Ryan, Christine E., Danielle M. Brander, Paul M. Barr, et al.. (2023). A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia. Leukemia. 37(4). 835–842. 2 indexed citations
3.
Atadja, Peter, Lin Gao, Paul Kwon, et al.. (2004). Selective Growth Inhibition of Tumor Cells by a Novel Histone Deacetylase Inhibitor, NVP-LAQ824. Cancer Research. 64(2). 689–695. 109 indexed citations
4.
Walker, Heather, John M. Whitelock, Pamela J. Garl, et al.. (2003). Perlecan Up-Regulation of FRNK Suppresses Smooth Muscle Cell Proliferation via Inhibition of FAK Signaling. Molecular Biology of the Cell. 14(5). 1941–1952. 48 indexed citations
5.
Garl, Pamela J., Janet M. Wenzlau, Heather Walker, et al.. (2003). Perlecan-Induced Suppression of Smooth Muscle Cell Proliferation Is Mediated Through Increased Activity of the Tumor Suppressor PTEN. Circulation Research. 94(2). 175–183. 47 indexed citations
6.
Remiszewski, Stacy, Lidia Sambucetti, Peter Atadja, et al.. (2002). Inhibitors of Human Histone Deacetylase:  Synthesis and Enzyme and Cellular Activity of Straight Chain Hydroxamates. Journal of Medicinal Chemistry. 45(4). 753–757. 90 indexed citations
7.
Walker, Heather, Guy L. Rowland, & Michael Boyes. (1991). Personality, Personal Epistemology, and Moral Judgment. Psychological Reports. 68(3). 767–772. 13 indexed citations
8.
Walker, Heather. (1991). PERSONALITY, PERSONAL EPISTEMOLOGY, AND MORAL JUDGMENT. Psychological Reports. 68(3). 767–767. 2 indexed citations
9.
Prince, J.L., et al.. (1982). Accelerated Stress Testing of Terrestrial Solar Cells. IEEE Transactions on Reliability. R-31(3). 258–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026